Differential Effects of Obesity, Hyperlipidaemia, Dietary Intake and Physical Inactivity on Type I versus Type IV Allergies.
allergy
diet and lifestyle
hyperlipidaemia
obesity
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
05 Jun 2022
05 Jun 2022
Historique:
received:
15
05
2022
revised:
30
05
2022
accepted:
01
06
2022
entrez:
10
6
2022
pubmed:
11
6
2022
medline:
14
6
2022
Statut:
epublish
Résumé
Alongside metabolic diseases (esp. obesity), allergic disorders are becoming increasingly prevalent. Since both obesity and allergies are highly impacted by environmental determinants, with this study we assessed the potential link between metabolic implications and two distinct types of allergies. Using cross-sectional data from the German FoCus cohort, Obesity and metabolic alterations were found significantly more prevalent in subjects with allergies. In fact, this relation was more pronounced in contact allergy than hay fever. Subsequent BMI-adjusted analysis reveals particular importance of co-occurring hyperlipidaemia for both allergy types. For contact allergy, we revealed a strong association to the dietary intake of poly-unsaturated fatty acids, particularly α-linolenic acid, as well as the enrichment of the corresponding metabolic pathway. For hay fever, there were no major associations to the diet but to a lower physical activity level, shorter duration of sleep, and an altered gut microbial composition. Finally, genetic predisposition for hyperlipidaemia was associated to both contact allergy and hay fever. Reflected by higher allergy prevalence, our findings indicate an impaired immune response in obesity and hyperlipidaemia, which is differentially regulated in type I and type IV allergies by an unfavourable lifestyle constellation and subsequent microbial and metabolic dysfunctions.
Sections du résumé
BACKGROUND
BACKGROUND
Alongside metabolic diseases (esp. obesity), allergic disorders are becoming increasingly prevalent. Since both obesity and allergies are highly impacted by environmental determinants, with this study we assessed the potential link between metabolic implications and two distinct types of allergies.
METHODS
METHODS
Using cross-sectional data from the German FoCus cohort,
RESULTS
RESULTS
Obesity and metabolic alterations were found significantly more prevalent in subjects with allergies. In fact, this relation was more pronounced in contact allergy than hay fever. Subsequent BMI-adjusted analysis reveals particular importance of co-occurring hyperlipidaemia for both allergy types. For contact allergy, we revealed a strong association to the dietary intake of poly-unsaturated fatty acids, particularly α-linolenic acid, as well as the enrichment of the corresponding metabolic pathway. For hay fever, there were no major associations to the diet but to a lower physical activity level, shorter duration of sleep, and an altered gut microbial composition. Finally, genetic predisposition for hyperlipidaemia was associated to both contact allergy and hay fever.
CONCLUSIONS
CONCLUSIONS
Reflected by higher allergy prevalence, our findings indicate an impaired immune response in obesity and hyperlipidaemia, which is differentially regulated in type I and type IV allergies by an unfavourable lifestyle constellation and subsequent microbial and metabolic dysfunctions.
Identifiants
pubmed: 35684151
pii: nu14112351
doi: 10.3390/nu14112351
pmc: PMC9182605
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Federal Ministry of Education and Research
ID : 0315539A
Organisme : Federal Ministry of Food and Agriculture
ID : 2816ERA14E
Références
Nutrients. 2019 Nov 22;11(12):
pubmed: 31766714
Cell. 2014 Mar 27;157(1):121-41
pubmed: 24679531
J Allergy Clin Immunol. 2009 May;123(5):1163-9, 1169.e1-4
pubmed: 19230960
Expert Rev Clin Immunol. 2015;11(9):993-1003
pubmed: 26099040
Ann Nutr Metab. 1999;43(4):195-204
pubmed: 10592368
PLoS One. 2016 Feb 26;11(2):e0150202
pubmed: 26919190
Allergo J Int. 2016;25(5):114-123
pubmed: 27656354
J Allergy Clin Immunol. 1996 Apr;97(4):985-90
pubmed: 8655895
J Allergy Clin Immunol. 2000 Sep;106(3):444-52
pubmed: 10984362
J Nutr. 2003 Feb;133(2):510-5
pubmed: 12566492
PLoS One. 2015 Mar 30;10(3):e0123265
pubmed: 25822975
Int Arch Allergy Immunol. 2017;174(2):67-76
pubmed: 29035883
BMC Bioinformatics. 2007 Mar 27;8:105
pubmed: 17389044
J Lipid Res. 2008 May;49(5):1137-46
pubmed: 18281723
J Nutr. 2007 Dec;137(12):2781-6
pubmed: 18029499
Int Arch Allergy Immunol. 2021;182(2):94-105
pubmed: 32971520
Ann Allergy Asthma Immunol. 2021 Feb;126(2):197-199
pubmed: 33122126
Am J Physiol Heart Circ Physiol. 2020 Jul 1;319(1):H76-H88
pubmed: 32442027
Cell Host Microbe. 2012 Nov 15;12(5):611-22
pubmed: 23159051
Front Immunol. 2018 Jul 17;9:1584
pubmed: 30065721
Int Forum Allergy Rhinol. 2018 Oct;8(10):1098-1106
pubmed: 29979840
BMJ Open. 2021 May 21;11(5):e043959
pubmed: 34020973
PLoS One. 2018 Aug 28;13(8):e0202683
pubmed: 30153310
Gut Microbes. 2022 Jan-Dec;14(1):2057778
pubmed: 35435797
Eur Respir J. 2004 Apr;23(4):575-82
pubmed: 15083757
Nat Genet. 2021 Feb;53(2):147-155
pubmed: 33462482
Metabolism. 2018 Jul;84:11-27
pubmed: 29195759
Obes Facts. 2016;9(6):379-391
pubmed: 27898428
Br J Dermatol. 1984 Jun;110(6):649-52
pubmed: 6428445
Sci Rep. 2015 Jun 11;5:9750
pubmed: 26065911
Public Health Nutr. 2015 Feb;18(3):530-6
pubmed: 24739266
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 May;56(5-6):698-706
pubmed: 23703488
Ann Allergy Asthma Immunol. 2021 Jul;127(1):100-108
pubmed: 33771681